Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportClinical Science

The Utility of BMIPP SPECT and Late Gadolinium Enhancement MRI: Prognostic Value in Patients with Cardiac Sarcoidosis

Atsushi Yamamoto, Michinobu Nagao, Kenji Fukushima, Kiyoe Ando, Risako Nakao, Yuka Matsuo, Mitsuru Momose, Koichiro Kaneko, Nobuhisa Hagiwara and Shuji Sakai
Journal of Nuclear Medicine June 2022, 63 (supplement 2) 2296;
Atsushi Yamamoto
1Department of Diagnostic Imaging & Nuclear Medicine, Tokyo Women’s Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michinobu Nagao
1Department of Diagnostic Imaging & Nuclear Medicine, Tokyo Women’s Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenji Fukushima
2Fukushima Medical Univesity
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kiyoe Ando
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Risako Nakao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuka Matsuo
1Department of Diagnostic Imaging & Nuclear Medicine, Tokyo Women’s Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitsuru Momose
3Momose Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koichiro Kaneko
4Tokyo Women's Medical University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nobuhisa Hagiwara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuji Sakai
1Department of Diagnostic Imaging & Nuclear Medicine, Tokyo Women’s Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

2296

Introduction: Sarcoidosis is a systemic chronic inflammatory disease characterized by the presence of noncaseating granulomas. Cardiac involvement is one of the major causes of disease-related death. Steroid therapy is the mainstay of treating cardiac sarcoidosis (CS). Previous studies reported that late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) could predict prognosis in patients with CS. However, the evaluation of LGE was limited due to implant of cardiac device or renal dysfunction. 123I-betamethyl-p-iodophenyl-pentadecanoic acid single-photon emission computed tomography (BMIPP) was developed to evaluate fatty acid metabolism and effective in detecting myocardial damage in CS. Present study aimed to investigate the relationship between LGE and myocardial damage obtained from BMIPP SPECT, and to explore the potential of BMIPP SPECT as prognostic factors in CS patients undergoing steroid therapy.

Methods: Forty-five CS patients who underwent BMIPP SPECT and LGE-CMR within 2 months were enrolled. The left ventricle was divided into 17 myocardial segments on BMIPP and LGE-CMR. BMIPP defects were assessed in each segment using a scoring system from 0 to 4 (0 normal; 1 mild; 2 moderate; 3 severe; 4 absent), and total BMIPP defect score (BDS) in the entire left ventricle were calculated. LGE in each segment was assessed using a scoring system from 0 to 2 (0 none; 1 partially positive; 2 homogeneously positive), and total LGE extent score (LES) in the entire left ventricle was also calculated. The relationship between BDS and LES was examined using Pearson’s correlation coefficient. The predictability of the BDS and LES for major adverse cardiac events (MACE), consisting of all-cause death, hospitalization due to heart failure, and recurrence or onset of sustained ventricular tachycardia and ventricular fibrillation, was analyzed using Kaplan–Meier analysis.

Results: BDS of the group with MACE was significantly higher than that of the group without MACE (25±14 vs. 11±10, p = 0.0008). LGE of patients with MACE was also significantly higher than that of patients without MACE (12.2±5.4 vs. 6.9±4.9, p = 0.0045). BDS showed a significant correlation with LES (r = 0.88, p < 0.0001). Patients with LES ≥9 had a significantly higher MACE rate than patients with BDS <9 (log-rank test, p = 0.0098). Patients with BDS ≥16 also had a significantly higher MACE rate than patients with BDS <16 (log-rank test, p = 0.0029).

Conclusions: Myocardial damage assessed by BMIPP SPECT correlated with LGE extent. Both BDS and LES have the predictive values of MACE in CS.In CS, many patients have cardiac devices implanted, including defibrillation, which limits the evaluation of CMR. In comparison, BMIIPP has the advantage of being performed without the influence of cardiac devices.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
June 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Utility of BMIPP SPECT and Late Gadolinium Enhancement MRI: Prognostic Value in Patients with Cardiac Sarcoidosis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The Utility of BMIPP SPECT and Late Gadolinium Enhancement MRI: Prognostic Value in Patients with Cardiac Sarcoidosis
Atsushi Yamamoto, Michinobu Nagao, Kenji Fukushima, Kiyoe Ando, Risako Nakao, Yuka Matsuo, Mitsuru Momose, Koichiro Kaneko, Nobuhisa Hagiwara, Shuji Sakai
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 2296;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Utility of BMIPP SPECT and Late Gadolinium Enhancement MRI: Prognostic Value in Patients with Cardiac Sarcoidosis
Atsushi Yamamoto, Michinobu Nagao, Kenji Fukushima, Kiyoe Ando, Risako Nakao, Yuka Matsuo, Mitsuru Momose, Koichiro Kaneko, Nobuhisa Hagiwara, Shuji Sakai
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 2296;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Role of FDG PET scan in evaluating the extent of viability using quantitative method in addition to routine visual method, and its impact on management and clinical outcome.
  • xSPECT-based myocardial perfusion scintigraphy: feasibility of myocardial uptake quantitation in patients with suspected coronary artery disease – a pilot study
  • Non-Invasive Measurement of Increased Vessel Wall Inflammation by [18F]FDG PET/CT in Patients with Multiple Myeloma upon Allogeneic Hematopoietic Cell Transplantation
Show more Clinical Science

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire